evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract
19574,GENE_SUMMARY,,IRS1 is a key mediator of insulin receptor signalling after activation by Insulin and IGF-1. It has oncogenic functions on a variety of tumor entities.,,2017-01-17,,3667,IRS1,insulin receptor substrate 1,False,ENST00000305123,NM_005544.2,HIRS-1,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
19575,GENE_BACKGROUND,,"Insulin receptor substrate 1 (IRS1) is one of the key mediator of Insulin receptor (INSR) signalling in cells (PMID: 1648180, 19029956). Upon activation of INSR IRS1 is phosphorylated and activated leading to the activation of the PI3-Kinase and MAPK pathway (PMID: 1648180, 11292874, 21597332). IRS1 has oncogenic functions in multiple tumor entities such as breast cancer and high IRS1 expression is associated with adverse prognosis (PMID: 17030631, 22337149). IRS-1 associates with BCL-2 and increases its anti-apoptotic functions (PMID: 10679027). IRS-1 interacts with GRB2 leading to JAK activation (PMID: 8491186, 8536716, 9492017). ETV6-NTRK3 induced cell transformation requires high levels of IRS-1 phosphorylation (PMID: 12173038). Phosphorylation of IRS1 S307 seems to abrogate its ability to mediate insulin receptor signalling (PMID: 11606564). Drugs that specifically target the insulin receptor pathway and IRS1 activity have been developed and clinically investigated (PMID: 19581933, 20807783).",,2017-01-17,,3667,IRS1,insulin receptor substrate 1,False,ENST00000305123,NM_005544.2,HIRS-1,False,19581933,Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions.,Oncogene,2018-08-27T20:09:00,28,34,3009-21,Gualberto A et al,doi: 10.1038/onc.2009.172,,0001-08-27,,12173038,ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.,Oncogene,2018-08-22T20:02:00,21,37,5684-95,Morrison KB et al,,,0001-08-22,,22337149,The insulin and insulin-like growth factor receptor family in neoplasia: an update.,Nature reviews. Cancer,2018-02-16T20:12:00,12,3,159-69,Pollak M,doi: 10.1038/nrc3215,,0001-02-16,,20807783,Targeting insulin-like growth factor signaling: rational combination strategies.,Molecular cancer therapeutics,2018-09-01T20:10:00,9,9,2447-9,Olmos D et al,doi: 10.1158/1535-7163.MCT-10-0719,,0001-09-01,,1648180,Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein.,Nature,0001-07-04,352,6330,1973-07-01,0001-01-07,,,0001-07-04,,17030631,Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2.,Molecular and cellular biology,2017-12-01T20:06:00,26,24,9302-14,Dearth RK et al,,,0001-12-01,,10679027,Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function.,Molecular biology of the cell,2018-02-01T20:00:00,11,2,735-46,Ueno H et al,,,0001-02-01,,19029956,Insulin and insulin-like growth factor signalling in neoplasia.,Nature reviews. Cancer,2017-12-01T20:08:00,8,12,915-28,Pollak M,doi: 10.1038/nrc2536,,0001-12-01,,11606564,Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action.,The Journal of biological chemistry,2018-01-11T20:02:00,277,2,1531-7,Aguirre V et al,,,0001-01-11,,8491186,The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.,The EMBO journal,0001-05-01,12,5,1929-36,Skolnik EY et al,,,0001-05-01,,8536716,Involvement of Janus kinases in the insulin signaling pathway.,European journal of biochemistry,0001-12-01,234,2,656-60,Giorgetti-Peraldi S et al,,,0001-12-01,,11292874,"Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein.","Science (New York, N.Y.)",2018-04-06T20:01:00,292,5514,104-6,Clancy DJ et al,,,0001-04-06,,21597332,The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer.,"Cell cycle (Georgetown, Tex.)",2018-06-01T20:11:00,10,11,1750-6,Shaw LM,,,0001-06-01,,9492017,Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor.,Endocrinology,0001-03-01,139,3,884-93,Gual P et al,,,0001-03-01,
